Moderna CEO's vaccine warning rattles global stock markets

Moderna CEO's vaccine warning rattles marketsПодробнее

Moderna CEO's vaccine warning rattles global stock marketsПодробнее

Moderna CEO on side effects of combination vaccineПодробнее

MIT Professor’s Moderna Stake on Brink of Topping $1 BillionПодробнее

Moderna CEO appears before Senate Hearing on COVID-19 vaccine pricingПодробнее

Coronavirus vaccine: Moderna CEO breaks down emergency use authorization, distribution, and efficacyПодробнее

Stocks Move Higher on Moderna Vaccine NewsПодробнее

Moderna CEO talks Omicron booster shots, 2022 COVID-19 vaccine sales forecasts, global vaccinationПодробнее

Moderna CEO: We can supply up to 3 billion Covid vaccine booster doses this yearПодробнее

Moderna CEO: ‘We are seeing very strong’ vaccine demandПодробнее

Moderna CEO: Could take weeks for more clarity on omicron Covid variantПодробнее

Moderna CEO on raising Covid vaccine manufacturing goalsПодробнее

Moderna CEO: Most exciting vaccine data is protection from severe Covid-19Подробнее

Moderna CEO Bancel: Future Covid vaccine booster will likely target omicron variantПодробнее

Coronavirus vaccine: Moderna CEO discusses vaccine developmentПодробнее

Moderna CEO Stephane Bancel talks business, vaccine demand, and medical advancesПодробнее

The Moderna CEO Just Spooked The Market | PreMarket PrepПодробнее

U.S. Stocks Climb on News of Moderna Vaccine ProgressПодробнее

Moderna vaccine news boosts stocks: Strategist discusses market rally and outlook for investorsПодробнее

Moderna CEO defends $130 COVID vaccine price in Senate hearing #shortsПодробнее